Natco Pharma Ltd on Thursday announced that its Kothur unit in Hyderabad has been classified as ‘Voluntary Action Indicated’ (VAI) by the US Food and Drug Administration (USFDA) following a recent inspection.
The company said in a regulatory filing that the US health regulator had carried out an inspection of its pharmaceutical division in Kothur, Hyderabad. It has now received the Establishment Inspection Report (EIR), confirming the VAI status for the facility.